Form 8-K - Current report:
SEC Accession No. 0001628280-24-049497
Filing Date
2024-12-02
Accepted
2024-12-02 08:08:12
Documents
26
Period of Report
2024-12-02
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aqst-20241202.htm   iXBRL 8-K 30039
2 EX-99.1 pressrelease-finalforrev.htm EX-99.1 13799
3 EX-99.2 q42024-prexndameetingsup.htm EX-99.2 13876
7 pressrelease-finalforrev001.jpg GRAPHIC 285089
8 pressrelease-finalforrev002.jpg GRAPHIC 305523
9 pressrelease-finalforrev003.jpg GRAPHIC 332087
10 pressrelease-finalforrev004.jpg GRAPHIC 42955
11 q42024-prexndameetingsup001.jpg GRAPHIC 91787
12 q42024-prexndameetingsup002.jpg GRAPHIC 284584
13 q42024-prexndameetingsup003.jpg GRAPHIC 119075
14 q42024-prexndameetingsup004.jpg GRAPHIC 133835
15 q42024-prexndameetingsup005.jpg GRAPHIC 115173
16 q42024-prexndameetingsup006.jpg GRAPHIC 62425
17 q42024-prexndameetingsup007.jpg GRAPHIC 30735
  Complete submission text file 0001628280-24-049497.txt   2678309

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aqst-20241202.xsd EX-101.SCH 1776
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aqst-20241202_lab.xml EX-101.LAB 21629
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aqst-20241202_pre.xml EX-101.PRE 12504
28 EXTRACTED XBRL INSTANCE DOCUMENT aqst-20241202_htm.xml XML 2719
Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 241517459
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)